Animal studies have shown that increased hepatic SREBP-1c is associated with insulin resistance, diabetes and hepatic steatosis, partially by the enhanced synthesis of lipotoxic saturated fatty acids and increased hepatic gluconeogenesis23, 24. This evidence concerns the gene SREBF1 and Insulin resistance.